Latest News by Industry
LATHAM, N.Y.--(BUSINESS WIRE)--Nov 17, 2022--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the Piper Sandler 34 th Annual Healthcare Conference at 10:10 a.m. ET on Wednesday, November 30, 2022.
A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients. `
The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20221117006020/en/
CONTACT: Investor Contact:
AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: ONCOLOGY MEDICAL SUPPLIES HEALTH MEDICAL DEVICES SURGERY PHARMACEUTICAL CARDIOLOGY
SOURCE: AngioDynamics, Inc.
Copyright Business Wire 2022.
PUB: 11/17/2022 04:01 PM/DISC: 11/17/2022 04:02 PM
http://www.businesswire.com/news/home/20221117006020/en